Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8851–8900 of 75461
On June 5, 2024, Mr. Ronen Faier notified the Board of Directors (the “Board”) of SolarEdge Technologies, Inc. (the “Company”) of his intention to retire as Chief Financial Officer of SolarEdge Technologies, Inc. (the “Company”) on a date to be agreed on between Mr. Faier and the Board following an approximately three-month transition period.
On June 4, 2024, Robert Hoglund, Senior Vice President and Chief Financial Officer (principal financial officer) of each of Consolidated Edison, Inc. (“Con Edison”) and Consolidated Edison Company of New York, Inc. (“CECONY”) announced his plan to retire from the role of the Chief Financial Officer on July 8, 2024.
On June 4, 2024, Kirkland B. Andrews resigned as Executive Vice President and Chief Financial Officer of the Evergy Companies effective on June 21, 2024 (the “Effective Date”).
On June 4, 2024, Nathan Jorgensen, Ph.D., M.B.A., notified Vor Biopharma Inc. (the “Company”) of his resignation as Chief Financial Officer of the Company, effective as of June 21, 2024 (the “Effective Date”), in order to pursue a new opportunity.
On June 4, 2024, Array Technologies, Inc. (the “Company”) and Kurt Wood, Chief Financial Officer of the Company (“CFO”), mutually determined that Mr. Wood would step down from his position as CFO, effective as of June 30, 2024.
terminated Curt Kole’s employment effective June 30, 2024 from all positions with the Company and its subsidiaries, including as the Company’s Executive Vice President of Precision Logistics and as Executive Vice President, Global Sales and Strategy of the Company’s wholly owned subsidiary PeriShip Global LLC.
the Company’s shareholders elected a new board member, Ellen S. Robinson to replace retiring board member Eric D. Sipf, effective immediately.
On June 7, 2024, John Stocchetti, Executive Vice President and Group Head, Mortgage Partnership Finance Program of the Federal Home Loan Bank of Chicago (Bank), notified the Bank that he intends to retire from the Bank, although he has not yet determined an official date for his retirement.
announcing the appointment of Daniel M. Chism as Chief Financial Officer of the Company, effective June 7, 2024, succeeding John Penver.
On June 5, 2024, Mr. Frederick D. Hrkac resigned as acting chief financial officer and principal accounting officer of BioSig Technologies, Inc. (“BioSig” or “Company”) effective as of the same date.
Mr. Nelson’s employment termination date is June 10, 2024 (the “Separation Date”) resigning from all positions including position as a non-employee Director on the Board of Directors, in lieu of an involuntary termination without cause.
William Cooke will retire and not stand for reelection as a director of the Company at the 2024 Annual Stockholder Meeting.
On June 9, 2024, Christopher Schaper resigned as a member of the Board, effective immediately.
Effective June 7, 2024, Taro Kawabe resigned as a member of the Board of Directors (the “Board”) of Aircastle Limited (the “Company”).
On June 6, 2024, Paul Purcell resigned as a director of Sezzle Inc. (the “Company”) effective immediately, and declined to stand for reelection at the Company’s 2024 Annual General Meeting of Stockholders.
Hunter Gary, Jesse A. Lynn and Steven Miller, who are employed by the Icahn Parties, resigned from the Company’s board of directors
Hunter Gary, Jesse A. Lynn and Steven Miller, who are employed by the Icahn Parties, resigned from the Company’s board of directors
Hunter Gary, Jesse A. Lynn and Steven Miller, who are employed by the Icahn Parties, resigned from the Company’s board of directors
On June 5, 2024, Cardiff Lexington Corporation (the “Company”) terminated Zia Choe from her position as Chief Accounting Officer of the Company in connection with a restructuring of the Company’s accounting department.
Mr. Black will succeed J. Barton Kalsu, who tendered his resignation on June 6, 2024 in order to explore other professional opportunities outside of the Company.
Mr. Williams succeeds Robert L. Lane, who will depart the company on June 30, 2024.
The disclosure under “Director Resignation” in Item 3.01 above is incorporated by reference into this Item 5.02.
On June 3, 2024, Mr. Raja A. Dakkuri provided Valley National Bancorp (the “Company”) with notice of his intent to resign from his position as Senior Executive Vice President—Chief Risk Officer of the Company effective June 21, 2024.
Mr. Gregory Freitag was not re-nominated for re-election.
On June 5, 2024, Plus Therapeutics, Inc. (the “Company”) received the resignation of Dr. Norman LaFrance, its Chief Medical Officer.
Mr. Rene Mladosich resigned his position as a director of the Company.
Mr. Koy D. Diepholz resigned his position as President, Chief Executive Officer, and interim Chief Financial Officer of the Company.
On June 6, 2024, L. Kian Granmayeh informed Carriage Services, Inc. (the “Company”) that he would resign from his position as Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer) of the Company effective July 1, 2024
On June 5, 2024, Mr. John P. Clancy, Jr., a director and the Chief Executive Officer of Enterprise Bancorp, Inc. (the “Company”) and its wholly owned subsidiary, Enterprise Bank & Trust Company (the “Bank”), notified the Boards of Directors of the Company and the Bank of his decision to retire from the Boards of Directors and as Chief Executive Officer of the Company and the Bank and transition to an executive advisor role.
Jason Aiken notified XPO, Inc. (the “Company”) of his resignation from the Board of Directors (the “Board”) of the Company effective as of June 6, 2024.
On June 5, 2024, Ms. Ekta Singh-Bushell notified TTEC Holdings, Inc., a Delaware company (the “Company” or “TTEC”) that she intends to resign as a member of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately following the next regularly scheduled Board meeting, which is currently scheduled for September 25-27 2024.
Mr. Turner will resign as the Chief Financial Officer of the Company effective June 17, 2024
the board of directors (the “Board”) of Cenntro Inc. (the “Company”) accepted the resignation of Stephen Markscheid as independent director of the Board effective April 3, 2024.
On June 4, 2024, Galera Therapeutics, Inc. (the “Company”) notified Robert A. Beardsley, Ph.D., the Company’s Chief Operating Officer, that his position is being eliminated in order to save costs as the Company continues to undertake a comprehensive review of strategic alternatives for both the Company and its portfolio of dismutase mimetics.
On June 6, 2024, the Board of Directors (the “Board”) of Semtech Corporation (“Semtech” or the “Company”) terminated Paul H. Pickle as President and Chief Executive Officer of the Company, without cause.
On June 6, 2024, Rob Perez notified the Board of Directors (the “ Board ”) of Third Harmonic Bio, Inc. (the “ Company ”) of his decision to resign as a Class I director of the Board, and as Chairperson of the Nominating and Governance Committee of the Board and a member of the Audit Committee of the Board, in each case effective as of June 6, 2024. Mr. Perez’s resignation was not related to any disagreement with the Company over any of its operations, policies, or practices.
On May 31, 2024, Mr. Theodore’s employment was involuntarily terminated without cause under circumstances that entitle him to severance benefits as described in the Company’s Form 8-K filed December 5, 2023.
Dr. Sara Lawrence-Lightfoot retired from the Company’s Board of Directors (the “ Board ”) effective June 5, 2024
On June 7, 2024, Edgio, Inc. (the “Company”) announced that Ajay Kapur has stepped down as Chief Technology Officer of the Company, effective immediately.
Mr. Dulac provided notice of his resignation from his position as the Company’s Chief Financial Officer on May 30, 2024, which resignation shall be effective as of June 14, 2024.
On June 4, 2024, John C. Marion, Executive Vice President and Chief Risk Officer of MVB Financial Corp. (the “Company”) and its wholly owned bank subsidiary, MVB Bank, Inc. (the “Bank” together with the Company, collectively referred to as “MVB”), provided notice of his resignation from his position with MVB to pursue another employment opportunity with another company, with such resignation to be effective August 2, 2024.
Director Shelley D. Spray did not stand for reelection at the Annual Meeting.
On June 6, 2024, Masateru Higashida and Kevin J. Conner resigned from the board of directors of the Company (the “Board”) and any committee of the Board of which they were a member . Mr. Higashida also resigned from his positions of Chairman of the Board, Chief Executive Officer, Secretary, and Treasurer.
On June 6, 2024, Masateru Higashida and Kevin J. Conner resigned from the board of directors of the Company (the “Board”) and any committee of the Board of which they were a member .
On June 3, 2024, Mr. Yumin Lin tendered his resignation as a member of the board of directors (the “Board”) and Chief Executive Officer of Fortune Valley Treasures, Inc. (the “Company”) due to personal reasons.
On June 6, 2024, Heng Fai Ambrose Chan notified Impact Biomedical, Inc. (the “Company”) that he is resigning as a member of the Board of Directors of the Company, effective immediately.
On June 6, 2024, Christopher Towers resigned from the Board of Directors (the “Board”) of Intelligent Bio Solutions Inc. (the “Company”), effective June 7, 2024.
On June 3, 2024, Manu Ohri’s employment as Chief Financial Officer at GT Biopharma, Inc. (the “Company”) was terminated.
In addition, Mr. Xilas resigned as Director on the Closing Date
On the Closing Date, June 5, 2024, Mr. James Xilas resigned as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, and Treasurer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.